• FirefoxInstall the new Firefox »
  •  Dow Down1.11% Nasdaq Down0.94%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    8.95 Mar 31, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 48,300   13,203   5,743   6,875  
    Cost of Revenue -   -   -   -  
    Gross Profit 48,300   13,203   5,743   6,875  
    Operating Expenses
    Research Development27,647  28,018  25,787  38,280  
    Selling General and Administrative6,872  7,095  6,456  6,040  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 13,781   (21,910) (26,500) (37,445)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes13,635  (22,282)(26,499)(37,451)
    Interest Expense -   -   -   -  
    Income Before Tax13,635  (22,282)(26,499)(37,451)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops13,635  (22,282)(26,499)(37,451)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 13,635   (22,282) (26,499) (37,451)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 13,635   (22,282) (26,499) (37,451)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.